{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:23:26Z","timestamp":1777382606442,"version":"3.51.4"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Medical Research Future Fund of Australia"},{"name":"National Health and Medical Research Council of Australia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The social, contextual, and behavioral determinants that influence care in patients at risk for invasive fungal diseases (IFD) are poorly understood. This knowledge gap is a barrier to the implementation of emerging antifungal stewardship (AFS) programs. We aimed to understand the barriers and enablers to AFS, opportunities for improvement, and perspectives of AFS for hematology patients at a major medical center in Australia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Semistructured, face-to-face interviews were conducted with 35 clinicians from 6 specialties (hematology, infectious diseases, pharmacy, nursing, radiology, respiratory), followed by thematic analysis mapped to a behavioral change framework.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Access to fungal diagnostics including bronchoscopy was identified as the key barrier to rational prescribing. Collective decision making was the norm, aided by an embedded stewardship model with on-demand access to infectious diseases expertise. Poor self-efficacy\/knowledge among prescribers was actually an enabler of AFS, because clinicians willingly deferred to infectious diseases for advice. A growing outpatient population characterized by frequent care transitions was seen as an opportunity for AFS but neglected by an inpatient focused model, as was keeping pace with emerging fungal risks. Ad hoc surveillance, audit, and feedback practices frustrated population-level quality improvement for all actors. Antifungal stewardship was perceived as a specialized area that should be integrated within antimicrobial stewardship but aligned with the cultural expectations of hematologists.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Antifungal stewardship is multifaceted, with fungal diagnostics a critical gap and outpatients a neglected area. Formal surveillance, audit, and feedback mechanisms are essential for population-level quality improvement. Resourcing is the next challenge because complex immunocompromised patients require personalized attention and audit of clinical outcomes including IFD is difficult.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaa168","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T15:28:14Z","timestamp":1590074894000},"source":"Crossref","is-referenced-by-count":5,"title":["Ushering in Antifungal Stewardship: Perspectives of the Hematology Multidisciplinary Team Navigating Competing Demands, Constraints, and Uncertainty"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7164-3108","authenticated-orcid":false,"given":"Michelle R","family":"Ananda-Rajah","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Alfred Health and Central Clinical School, Monash University, Melbourne, Victoria, Australia"},{"name":"General Medical Unit, Alfred Health, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Fitchett","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Alfred Health and Central Clinical School, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darshini","family":"Ayton","sequence":"first","affiliation":[{"name":"Monash Partners Academic Health Science Centre, Clayton, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton Y","family":"Peleg","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Alfred Health and Central Clinical School, Monash University, Melbourne, Victoria, Australia"},{"name":"Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun","family":"Fleming","sequence":"first","affiliation":[{"name":"Clinical Haematology, Alfred Health and Central Clinical School, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliza","family":"Watson","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Alfred Health and Central Clinical School, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Cairns","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Alfred Health, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trisha","family":"Peel","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Alfred Health and Central Clinical School, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,5,21]]},"reference":[{"key":"2020061714032368900_CIT0001","article-title":"Antimicrobial stewardship from principles to practice","author":"Enoch","year":"2018","journal-title":"Br Soc Antimicrob Chemother"},{"key":"2020061714032368900_CIT0002","first-page":"969","article-title":"Issues in antifungal stewardship: an opportunity that should not be lost","volume":"72","author":"Wattal","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2020061714032368900_CIT0003","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/jac\/dkx388","article-title":"A systematic review of interventions and performance measures for antifungal stewardship programmes","volume":"73","author":"Bienvenu","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2020061714032368900_CIT0004","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/QCO.0b013e32834e0680","article-title":"The case for antifungal stewardship","volume":"25","author":"Ananda-Rajah","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"2020061714032368900_CIT0005","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/cid\/ciy776","article-title":"Estimation of direct healthcare costs of fungal diseases in the United States","volume":"68","author":"Benedict","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020061714032368900_CIT0006","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fphar.2019.00080","article-title":"The Yin and Yang of current antifungal therapeutic strategies: how can we harness our natural defenses?","volume":"10","author":"Di Mambro","year":"2019","journal-title":"Front Pharmacol"},{"key":"2020061714032368900_CIT0007","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"key":"2020061714032368900_CIT0008","doi-asserted-by":"crossref","first-page":"e1006290","DOI":"10.1371\/journal.ppat.1006290","article-title":"Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally","volume":"13","author":"Chowdhary","year":"2017","journal-title":"PLoS Pathog"},{"key":"2020061714032368900_CIT0009","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?","volume":"62","author":"Verweij","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020061714032368900_CIT0010","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020061714032368900_CIT0011","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/myc.12329","article-title":"Antifungal stewardship in daily practice and health economic implications","volume":"58","author":"Mu\u00f1oz","year":"2015","journal-title":"Mycoses"},{"key":"2020061714032368900_CIT0012","doi-asserted-by":"crossref","first-page":"i45","DOI":"10.1093\/jac\/dkq441","article-title":"Optimizing management of invasive mould diseases","volume":"66","author":"Agrawal","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2020061714032368900_CIT0013","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1093\/jac\/dky222","article-title":"Driving sustainable change in antimicrobial prescribing practice: how can social and behavioural sciences help?","volume":"73","author":"Lorencatto","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2020061714032368900_CIT0014","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/cid\/ciy844","article-title":"The differences in antibiotic decision-making between acute surgical and acute medical teams: an ethnographic study of culture and team dynamics","volume":"69","author":"Charani","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020061714032368900_CIT0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2016.09.002","article-title":"Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations","volume":"31","author":"Pagano","year":"2017","journal-title":"Blood Rev"},{"key":"2020061714032368900_CIT0016","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3390\/jcm8091390","article-title":"Closing the gap in surveillance and audit of invasive mold diseases for antifungal stewardship using machine learning","volume":"8","author":"Baggio","year":"2019","journal-title":"J Clin Med"},{"key":"2020061714032368900_CIT0017","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1099\/jmm.0.000612","article-title":"An investigation of antifungal stewardship programmes in England","volume":"66","author":"Micallef","year":"2017","journal-title":"J Med Microbiol"},{"key":"2020061714032368900_CIT0018","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cmi.2018.08.020","article-title":"Prioritizing research areas for antibiotic stewardship programmes in hospitals: a behavioural perspective consensus paper","volume":"25","author":"Rzewuska","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2020061714032368900_CIT0019","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1749-6632.2012.06829.x","article-title":"Risk stratification for invasive aspergillosis in immunocompromised patients","volume":"1272","author":"Herbrecht","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"2020061714032368900_CIT0020","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s15010-015-0742-5","article-title":"Hospital use of systemic antifungal drugs: a multi-center surveillance update from Germany","volume":"43","author":"Gross","year":"2015","journal-title":"Infection"},{"key":"2020061714032368900_CIT0021","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5694\/mja11.10809","article-title":"Early experience with antimicrobial stewardship ward rounds at a tertiary referral hospital","volume":"196","author":"Cairns","year":"2012","journal-title":"Med J Aust"},{"key":"2020061714032368900_CIT0022","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Implement Sci"},{"key":"2020061714032368900_CIT0023","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13012-017-0605-9","article-title":"A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems","volume":"12","author":"Atkins","year":"2017","journal-title":"Implement Sci"},{"key":"2020061714032368900_CIT0024","doi-asserted-by":"crossref","first-page":"l2068","DOI":"10.1136\/bmj.l2068","article-title":"Spreading and scaling up innovation and improvement","volume":"365","author":"Greenhalgh","year":"2019","journal-title":"BMJ"},{"key":"2020061714032368900_CIT0025","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/bmjqs-2018-008208","article-title":"Redesigning care: adapting new improvement methods to achieve person-centred care","volume":"28","author":"Bhattacharyya","year":"2019","journal-title":"BMJ Qual Saf"},{"key":"2020061714032368900_CIT0026","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijantimicag.2014.11.014","article-title":"Time for action-Improving the design and reporting of behaviour change interventions for antimicrobial stewardship in hospitals: early findings from a systematic review","volume":"45","author":"Davey","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"2020061714032368900_CIT0027","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cmi.2018.09.022","article-title":"ESCMID generic competencies in antimicrobial prescribing and stewardship: towards a European consensus","volume":"25","author":"Dyar","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2020061714032368900_CIT0028","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jhin.2016.03.011","article-title":"Barriers to uptake of antimicrobial advice in a UK hospital: a qualitative study","volume":"93","author":"Broom","year":"2016","journal-title":"J Hosp Infect"},{"key":"2020061714032368900_CIT0029","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1177\/1049732317721478","article-title":"Myth, manners, and medical ritual: defensive medicine and the fetish of antibiotics","volume":"27","author":"Broom","year":"2017","journal-title":"Qual Health Res"},{"key":"2020061714032368900_CIT0030","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don\u2019t physicians follow clinical practice guidelines? A framework for improvement","volume":"282","author":"Cabana","year":"1999","journal-title":"JAMA"},{"key":"2020061714032368900_CIT0031","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/jac\/dkz308","article-title":"Emotional, cognitive and social factors of antimicrobial prescribing: can antimicrobial stewardship intervention be effective without addressing psycho-social factors?","volume":"74","author":"Donisi","year":"2019","journal-title":"J Antimicrob Chemother"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaa168\/33245646\/ofaa168.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/6\/ofaa168\/33399573\/ofaa168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/6\/ofaa168\/33399573\/ofaa168.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T18:06:26Z","timestamp":1592417186000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaa168\/5841635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,21]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaa168","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6]]},"published":{"date-parts":[[2020,5,21]]},"article-number":"ofaa168"}}